- In April 2023, Orthofix Medical Inc., a U.S.-based medical device company, introduced two new access retractor systems, the Lattus Lateral Access System and the Fathom Pedicle-Based Retractor System. These systems are designed to assist surgeons in minimally invasive spine (MIS) procedures, enhancing surgical workflow, improving visualization, and complementing Orthofix's comprehensive procedural solutions for conditions including vertebral compression fractures
- In March 2023, research on innovative minimally invasive implants for osteoporotic vertebral compression fractures (OVCFs) gained traction, with studies highlighting new implants such as StaXx FX, Vertebral Body Stenting, Vesselplasty, Sky Bone Expander, Kiva, Spine Jack, Osseofix, Optimesh, Jack, and V-strut. These advancements aim to overcome the limitations of traditional procedures such as vertebroplasty and kyphoplasty by improving endplate reduction and reducing complications such as cement leakage and adjacent vertebral fractures
- In 2023, significant technological advancements continued to drive the vertebroplasty and kyphoplasty devices market. These innovations include improved biomaterial-based implants designed for higher strength and reduced cement leakage, and enhanced usability for easier procedures. Product developers are increasingly focusing on affordability and ease of utility to meet the rising demand for effective, minimally invasive care for spine fractures
- In September 2022, RevBio was awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health. This grant is enabling the company to further develop its patented bone adhesive technology, Tetranite, for the treatment of vertebral compression fractures, indicating ongoing research and development into novel biomaterial solutions for VCF management
